ReviewBlood cancer journal2025

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Philippe Moreau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.